Tempus AI Stock Looks Risky, But Its Data Flywheel Could Be Powerful
Tempus AI (NASDAQ:TEM) sits at the intersection of artificial intelligence, genomics, oncology, and drug development. That combination has created a compelling growth story, especially as the company expands artificial intelligence tools and biopharma partnerships. The stock’s challenge is simple: growth is impressive, but Wall Street still needs proof that the model can scale profitably. Stock … Read more
